Berman McAleer’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Buy
595
+24
+4% +$24.5K 0.08% 86
2026
Q1
$525K Buy
571
+39
+7% +$39.5K 0.07% 93
2025
Q4
$572K Buy
532
+1
+0.2% +$956 0.08% 88
2025
Q3
$405K Buy
+531
New +$395K 0.06% 104

Other funds holding LLY

Berman McAleer's LLY Position: Q2 2026 in Review

Berman McAleer increased its Eli Lilly (LLY) stake by 4.2% in Q2 2026, buying an estimated $24.5K and bringing the position to 595 shares worth $713K. The position accounts for 0.08% of the portfolio, ranked #86.

Berman McAleer first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Berman McAleer held 595 shares of Eli Lilly worth $713K as of Q2 2026.
  • Berman McAleer bought 24 Eli Lilly shares in Q2 2026, an estimated $24.5K.
  • Eli Lilly made up 0.08% of Berman McAleer's portfolio in Q2 2026, its #86 holding.
  • Berman McAleer first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Berman McAleer's 13F filing for Q2 2026, filed 16 Jul 2026.